Interesting CBOE Put And Call Options For March 27th

Cboe Global Markets (CBOE) options present income-oriented opportunities: a $270 put is bid $5.70 (net cost basis $264.30 vs. stock price $274.69), with a 62% chance to expire worthless and a 2.11% return (15.42% annualized) if so. A $280 covered call is bid $6.20; selling it after buying the stock at $274.69 would yield 4.19% if called by the March 27 expiration and has a 53% probability of expiring worthless, representing a 2.26% premium boost (16.49% annualized). Implied volatility is 26% on the put and 23% on the call versus a 12‑month trailing volatility of 22%.

Analysis

Market structure: CBOE benefits directly — option sellers, retail option flow businesses and market-makers collect elevated premia (puts IV 26% vs realized 22%), while directional option buyers are relatively disadvantaged if vols mean-revert. A persistent IV premium of ~4 pts signals higher demand for downside protection versus call upside, implying skew-driven revenue for CBOE’s fee/clearing engines and greater liquidity capture for trading desks.

Risk assessment: Near-term (days–weeks) the key tail risk is a volatility spike from macro shocks (Fed surprise, CPI miss) that would widen skew and force losses for naked premium sellers; operational risk (exchange outage) is idiosyncratic but high-impact. Over months, revenues map to options ADV — a 10% decline in ADV would meaningfully compress EPS given fixed-cost leverage; regulatory changes to market structure/fee schedules are low-probability but high-impact over quarters/years.

Trade implications: Immediate tactical income trades (sell Mar27 $270 put or buy stock/sell Mar27 $280 covered call) offer 2–4% gross return to expiration (annualized ~15–16%), attractive for defined-risk yield if position sizes are capped. For volatility exposure, prefer defined-risk credit put spreads (e.g., sell 270 / buy 260 Mar27) rather than naked short puts; consider a small relative long CBOE vs NDAQ for 3–6 months if you expect continued options-led revenue growth.

Contrarian angles: Consensus underestimates assignment risk and capital drag for aggressive put sellers during volatility spikes — being assigned at $264.30 can concentrate equity risk. Conversely, IV > realized suggests selling premium is not fully priced for sudden vol jumps; historical parallels (2018, 2020) show exchange revenues zipped higher with vol, so owning CBOE into macro events can be binary — either steady income or outsized upside on vol-driven fee expansion.

Key Decisions for Investors

• Establish a tactical sell-to-open CBOE (CBOE) Mar27 $270 put position sized to 1–2% of portfolio notional; collect $5.70, breakeven $264.30, roll or buy back if CBOE < $260 or IV rises >6 pts to limit skew risk.
• Buy CBOE shares up to 1–2% portfolio and sell Mar27 $280 covered calls (receive $6.20) to lock 4.19% to-expiration return; set hard exit if assigned at $280 or if share price > $290 (take profits) or if IV falls >5 pts (reprice premium).
• Prefer defined-risk volatility sell: enter Mar27 270/260 put credit spreads (sell 270, buy 260) sized max 0.5% portfolio risk per spread to capture elevated put IV while limiting tail exposure; cut if spread mark-to-market widens to 50% of max loss.
• Initiate a small relative-value pair: long CBOE vs short NDAQ equal-dollar (horizon 3–6 months) to express options-volume outperformance; stop-loss if relative performance moves against by >7% or sector ADV drops >10% quarter-over-quarter.